Get startedLog in
    Picture of Apogee Therapeutics logo

    APGE — Apogee Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Abbvie To Acquire Apogee Therapeutics, Deepening Immunology Portfolio

    Picture of Apogee Therapeutics logoApogee Therapeutics
    22/06/2026 12:51
    BRIEF-Abbvie To Acquire Apogee Therapeutics, Deepening Immunology Portfolio
    June 22 (Reuters) - Abbvie Inc ABBV.N:
    • ABBVIE TO ACQUIRE APOGEE THERAPEUTICS, DEEPENING IMMUNOLOGY PORTFOLIO
    • ABBVIE - APOGEE SHAREHOLDERS TO RECEIVE $135.11 PER SHARE IN CASH
    • ABBVIE - DEAL VALUES APOGEE AT $10.9 BILLION EQUITY VALUE
    • ABBVIE - DEAL EXPECTED TO BE ACCRETIVE TO ABBVIE'S ADJUSTED DILUTED EPS BEGINNING IN 2032
    • ABBVIE - DEAL EXPECTED TO CLOSE IN Q3 2026
    Source text: ID:nPnbpgVMsa
    Further company coverage: ABBV.N

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Apogee Therapeutics

    See all news